Clovis Oncology Denmark ApS: Financial statements 2020
CVR: 38721682
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Clovis Oncology Denmark ApS (CVR 38721682) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,657,621 and a net result of DKK 43,896 compared with DKK 65,187 the year before. That is a decrease of 13.9% compared with the year before. Equity in the 2020 report amounted to DKK 252,726. The solvency ratio was 18.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,657,621
- Profit/Loss
- DKK 43,896
- Equity
- DKK 252,726
- Total Assets
- DKK 1,390,428
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 1.7M | 44K | 253K | 1 |
| 2019 | - | 1.9M | 65K | 209K | 1 |
| 2018 | - | 4.5M | 21K | 50K | 2 |
Official annual report
How creditworthy is Clovis Oncology Denmark ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Clovis Oncology Denmark ApS has published its annual report for 2019. Gross profit came to DKK 1,924,969, and the net result was DKK 65,187.
About Clovis Oncology Denmark ApS
Clovis Oncology Denmark ApS was a Danish company of the type Anpartsselskab based in Allerød, founded in 2017. The company has been dissolved on 5 June 2025. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company has 1 employee (2023). In 2023, the company reported a gross profit of DKK -1,276,497 and a net result of DKK -1,290,249 compared with DKK -683,391 the year before. Equity in the 2023 report amounted to DKK -356,205.